NCT01440699View on ClinicalTrials.gov

Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 11, 2012

Study Completion Date

November 8, 2012

Conditions
Crohn
Interventions
BIOLOGICAL

Allogenic human adipose-derived stem cells

ALLO-ASC 1xE7 cells/mL is injected once along the fistula. If there is no safety issue for 4 weeks, 3 more people could be enrolled who are subject to ALLO-ASC 3xE7 cells/mL.

Trial Locations (3)

Unknown

Keonghee Medical Center, Seoul

Seoul National University Hospital, Seoul

Yeonsei Medical Center, Seoul

All Listed Sponsors
lead

Anterogen Co., Ltd.

INDUSTRY

NCT01440699 - Study of Allogenic Adipose-derived Stem Cells in Crohn's Fistula | Biotech Hunter | Biotech Hunter